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Abstract 
Renal Sensory Nerves Increase Sympathetic Nerve Activity and Blood Pressure 
in 2-Kidney 1-Clip Hypertensive Mice 
 
Jason Ong, BPhil 
 
University of Pittsburgh, 2020 
 
 
 
 
Renal denervation lowers arterial blood pressure (ABP) in multiple clinical trials and some 
experimental models of hypertension. These antihypertensive effects have been attributed to the 
removal of renal afferent nerves. The purpose of the present study was to define the function, 
anatomy, and contribution of mouse renal sensory neurons to a renal-nerve dependent model of 
hypertension. First, electrical stimulation of mouse renal afferent nerves produced frequency-
dependent increases in ABP that were eliminated by ganglionic blockade. Stimulus-triggered 
averaging revealed renal afferent stimulation significantly increased splanchnic, renal, and lumbar 
sympathetic nerve activity (SNA). Second, kidney injection of wheat germ agglutinin into male 
C57Bl6 mice (12-14 weeks, Jackson Laboratories) produced ipsilateral labeling in the T11-L2 
dorsal root ganglia. Next, 2K1C hypertension was produced in male C57Bl6 mice (12-14 weeks, 
Jackson Laboratories) by placement of a 0.5mm length of PTFE tubing around the left renal artery. 
2K1C mice displayed an elevated ABP measured via telemetry and greater fall in mean ABP to 
ganglionic blockade at day 14 or 21 vs day 0. Renal afferent discharge was significantly higher in 
2K1C-clipped versus 2K1C-unclipped or sham kidneys. In addition, 2K1C-clipped versus 2K1C-
unclipped or sham kidneys had lower renal mass and higher mRNA levels of several pro-
inflammatory cytokines. Finally, both ipsilateral renal denervation (10% phenol) or selective 
denervation of renal afferent nerves (periaxonal application of 33 mM capsaicin) at time of 
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clipping resulted in lower ABP of 2K1C mice at Days 14 or 21. These findings suggest mouse 
renal sensory neurons are activated to increase SNA and ABP in 2K1C hypertension. 
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1.0 Introduction 
Renal denervation lowers arterial blood pressure (ABP) in several experimental models of 
hypertension including the Spontaneously Hypertensive Rat, Deoxycorticosterone-Salt Model, 
and 2-Kidney-1-Clip (2K1C) (DiBona and Kopp 1997, Osborn and Foss 2017). In addition, the 
majority of clinical trials report renal denervation lowered ABP in humans (Symplicity HTN-1, 
Symplicity HTN-2, DENERHTN, and SPYRAL) (Krum, Schlaich et al. 2009, Krum, Schlaich et 
al. 2014, Azizi, Sapoval et al. 2015, Townsend, Mahfoud et al. 2017). The therapeutic effects of 
renal denervation have been attributed to the removal of sympathetic efferent and/or afferent fibers 
(Osborn and Banek 2018).  
Renal efferent or sympathetic nerves originate in the intermediolateral cell column of the 
spinal cord from T6-L2, synapse in the paravertebral chain ganglia and prevertebral ganglia and 
project down along the renal artery and vein. These nerves innervate renal arterioles, 
juxtaglomerular cells, and the entire renal tubular system (Osborn and Foss 2017). A number of 
studies indicate that activation of renal efferent fibers increases renin secretion and promotes 
tubular sodium reabsorption (Osborn and Foss 2017). In regard to the therapeutic effects of renal 
denervation, renal denervation in humans lowered total peripheral resistance without changes in 
cardiac output (Ewen, Cremers et al. 2015). Additionally, renal denervation lowered the renal 
resistivity index without changes in glomerular filtration rate or urinary albumin excretion 
(Mahfoud, Cremers et al. 2012).  
The second class of renal nerves are afferent or sensory nerves. Immunohistochemical 
staining of sensory nerves with calcitonin gene-related peptide reveal these nerves directly 
innervate the pelvic wall and to a lesser extent the renal vasculature. Sensory nerve fibers project 
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centrally through T6 and L4 DRG, with the majority in T12-T13. These nerves synapse in the 
ipsilateral dorsal horn of Laminae I, III and IV of the spinal cord, onto interneurons of the central 
nervous system that project to areas associated with cardiovascular regulation, such as the rostral 
ventrolateral medulla. Some renal sensory nerves may also project directly to the brainstem (Kopp 
2015). Stimulation of renal afferent fibers in rats and cats increased ABP (Stella, Golin et al. 1984, 
Caverson and Ciriello 1987, Stella, Weaver et al. 1987, Simon, Kasting et al. 1989). Direct 
recording of renal afferent activity indicates these fibers respond to mechanical and chemical 
stimuli (Recordati, Moss et al. 1978, Recordati, Moss et al. 1980, Recordati, Moss et al. 1981). 
Increased renal pelvic pressure as low as 3 mmHg activates renal sensory nerves. In addition, there 
are two groups of chemosensitive renal sensory nerves. R1 receptors are not spontaneously active 
but increase in firing rate under renal ischemia induced by renal artery occlusion. R2 receptors 
have a basal firing rate which increases to changes in pelvic urine composition, including high 
NaCl concentration (3-5%) and mannitol (1M) (Recordati, Moss et al. 1978, Recordati, Moss et 
al. 1980, Recordati, Moss et al. 1981). 
In regards to the contribution of renal afferents on the antihypertensive effects of renal 
denervation, dorsal rhizotomy to surgically remove all types of sensory fibers across multiple 
levels of the spinal cord and end-organs lowered ABP in some experimental models of 
hypertension (Wyss, Aboukarsh et al. 1986, Campese and Kogosov 1995). In addition, renal 
denervation in humans decreased muscle sympathetic nerve activity (SNA) (Hering, Lambert et 
al. 2013, Hering, Marusic et al. 2014, Grassi, Seravalle et al. 2015), reduced resting plasma glucose 
(Witkowski, Prejbisz et al. 2011), and reduced cardiac arrhythmias (Linz, Hohl et al. 2018). 
Recently, periaxonal application of capsaicin to selectively ablate renal sensory fibers reduced 
ABP in deoxycorticosterone-salt rat (Banek, Knuepfer et al. 2016) but not in the Dahl-salt-
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sensitive rat (Foss, Fink et al. 2016), angiotensin II-salt rat (Foss, Fiege et al. 2018), and 
angiotensin II-infused mouse (Xiao, Kirabo et al. 2015) models of hypertension. Altogether, these 
observations suggest that the antihypertensive effects of renal denervation may be partly attributed 
to removal of renal afferent nerves in certain models of hypertension. 
The majority of data regarding renal sensory nerves originates from studies performed in 
rats or larger animal models. Although mice currently represent the most common biomedical 
research model and transgenic lines provide a platform to address unique research questions, no 
information is currently available of mouse renal sensory nerves regarding the function, anatomical 
location of cell bodies, and contribution to neurogenic hypertension. Therefore, the purpose of the 
present study was to lay a foundational framework of mouse renal sensory nerves and then test the 
contribution of these nerves in an established renal nerve-dependent model of hypertension. The 
current study utilized an array of approaches including renal afferent nerve stimulation and 
simultaneous sympathetic nerve recordings, neuronal anatomical tracing, direct renal afferent 
nerve recording, and total versus selective afferent renal nerve denervation in a renovascular of 
2K1C model of hypertension.  
Renovascular hypertension produced by renal stenosis is the primary cause of secondary 
hypertension, accounting for 2-5% of systemic hypertension (de Mast Q 2009). Experimentally, 
renal stenosis is produced by placement of a fixed diameter cuff around the renal artery. The initial 
hypertension is mediated by the renin-angiotensin-aldosterone system, as administration of 
angiotensin converting enzyme inhibitors or angiotensin receptor blockers attenuates/blocks the 
increased blood pressure (Romero et al. 1977). Chronically, blockade of the RAAS does not lower 
blood pressure to the same extent, suggesting other mechanisms. At this stage, this elevated ABP 
may be neurogenically mediated given a greater drop to ganglionic blockade. Furthermore, renal 
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denervation has been shown to lower ABP in several models of hypertension. However, there are 
limited data to directly assess the anti-hypertensive effect of renal denervation (whether efferent 
or afferent) in this cohort (Krum, Schlaich et al. 2009, Krum, Schlaich et al. 2014, Azizi, Sapoval 
et al. 2015, Townsend, Mahfoud et al. 2017).  
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2.0 Methods 
All of the experimental procedures conform to the National Institutes of Health Guide for 
the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and 
Use Committee at the University of Pittsburgh School of Medicine. Male C57Bl6J mice (8-12 
weeks of age, strain 00664, Jackson Laboratories) were housed in a temperature-controlled room 
(22±1˚C), fed 0.1% NaCl chow (D17020, Research Diets), and given access to deionized water. 
2.1 Experiment 1 
Experiment 1 investigated whether activation of mouse renal sensory nerves increases SNA 
and ABP. Mice (n=6) were anesthetized with isoflurane and instrumented with femoral arterial 
and venous catheters. Body temperature was maintained at 37.0±0.2˚C through a servo-controlled 
temperature controller and rectal probe (CWE, Inc). Through a retroperitoneal incision, the right 
renal nerve was isolated, placed on bipolar stainless-steel electrodes, cut distal, and insulated with 
KWIK-SIL. After the mouse stabilized for >10 min at 1.8% isoflurane, the renal afferent nerves 
were stimulated electrically (1ms pulse, 10s train, 200uA) at various frequencies (2, 5, 10, 20, 30, 
50 Hz) in a random order separated by 5 min. To test the contribution of the sympathetic nervous 
system, the stimulation was repeated after administration of the ganglionic blocker 
chlorisondamine (5mg/kg, IV). The contribution of vasopressin was tested in a half of the animals 
by administration of [β-Mercapto-β,β-cycloptenamethyleneproionyl1,O-me-Tyr2,Arg8]-
vasopressin (10ug/kg, IV) prior to chlorisondamine. In a second set of mice anesthetized with 
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isoflurane (n=4), the left splanchnic, renal, and lumbar sympathetic nerves were isolated, placed 
on bipolar stainless-steel electrodes, and insulated with KWIK-SIL. Signals were filtered (100-
1000 Hz), digitized (2 kHz), rectified, and integrated (10ms time constant) using a Micro1401 and 
Spike2 software (Cambridge Electronic Design). Due to electrical artifacts produced by electrical 
stimulation of the renal afferent nerves, stimulus-triggered averaging was performed before and 
after a single electrical pulse was applied to the renal afferent nerve (1ms duration, 30 sweeps, 
100uA). To evaluate whether the type of anesthesia impacted these cardiovascular responses, renal 
afferent stimulation was repeated in mice (n=3) anesthetized with urethane (1.2mg/kg body 
weight, IV) after induction with isoflurane. 
2.2 Experiment 2 
Experiment 2 identified the location of renal sensory neurons. Mice (n=4) were 
anesthetized with isoflurane. After a midline laparotomy to visualize the kidneys, a glass 
micropipette (OD: 20-40µm) containing Wheat-Germ-Agglutinin (WGA tagged with Alexa Fluor 
488 or 594, 10%) was lowered into the kidneys using coordinates relative to the renal hillus: 1.5-
2.0mm lateral and 1.5-1.7mm ventral to the surface of the kidney. The injection volume of 500nL 
per site. Two additional injections per kidney were performed in which the pipette was moved 1.5-
2.0 mm toward each pole and using the same depth. These sites were targeted are prior studies in 
rats indicated the sensory nerves largely innervate the renal pelvis (Marfurt and Echtenkamp 
1991). Each kidney within the same mouse received a different WGA-Alexa Fluor tracer. At 5-7 
days later, animals were anesthetized with isoflurane and perfused transcardially with 4% 
paraformaldehyde (in 10mM PBS, pH 7.3). The DRG at T5-L3 and nodose ganglia were harvested, 
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post-fixed in 4% paraformaldehyde for 1 hr at 4˚C, immersed in 30% sucrose overnight, and 
sectioned at 20µm using a cryostat. Labeled cells were visualized and quantified using a Leica 
DM6000b epifluorescence microscope at every other section by 2 independent researchers. To 
ensure the labeling was dependent on renal nerve transport versus leakage into the bloodstream, 
the renal tracer injections were performed in an additional set of mice (n=3) after total renal nerve 
denervation by surgical removal of the renal nerve and 10% phenol application to the renal vessels 
(see denervation protocol below). 
2.3 Experiment 3 
Experiment 3 examined the time-course and contribution of the sympathetic nervous 
system to 2K1C hypertension. Mice were anesthetized with isoflurane (2-3% in 100% oxygen) 
and instrumented with PA-C10 telemetry units (Data Sciences) advanced 1.5 cm into the femoral 
artery with the transmitter body secured subcutaneously (sc) in the flank. Mice were treated with 
Buprenex (0.03 mg/kg, sc, 2x per day for 48 hours) and enrofloxacin (2 mg/kg, sc), returned to 
home cages, and given 1 week to recover before experiments began. Telemetry data was analyzed 
beat-to-beat for systolic and diastolic ABP. Mean ABP was calculated by diastolic plus 1/3 pulse 
pressure. Data were analyzed between 10AM-4PM and 10PM-4AM (lights on 7AM-7PM). After 
a 7 day recovery and 3 day baseline recording, 2K1C model of hypertension was produced using 
methods described previously (Warner, Cheng et al. 2012, Kashyap, Boyilla et al. 2016). Mice 
were anesthetized with isoflurane (2-3% in 100% oxygen). After a retroperitoneal incision, the left 
kidney was gently retracted. A small section at the midpoint of the renal artery was isolated free 
from the renal vein and/or renal nerves. A 0.5mm length PTFE tubing (ID: 0.008 x OD: 0.014, 
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Braintree Scientific SUBL140) was cut longitudinally, placed around the renal artery, and secured 
by two 10-0 circumferential sutures. In control mice, the left kidney and renal artery were exposed 
but no clip was implanted. The incisions were closed with suture, and animals treated with 
Buprenex and enrofloxacin. Ganglionic blockade with hexamethonium (30mg/kg, ip) was 
performed on Day 0 (before the renal clip surgery), 14, and 21 days relative to 2K1C surgery. On 
days 22-23, mice were anesthetized with isoflurane (3% in 100% oxygen) and perfused 
transcardially with saline and 4% paraformaldehyde (in 10mM PBS, pH 7.3). The kidneys were 
harvested and weighed. A subset of kidneys was embedded in paraffin, sectioned at 3 µm, and 
counterstained with H&E. The remaining kidneys were processed for immunofluorescence 
visualization of tyrosine hydroxylase and TRPV1 as described below (Experiment 5). 
A second set of 2K1C and sham mice (n=4 per group) without telemetry units were 
produced to assess renal cytokine expression using qPCR. At 3 weeks after surgery, mice were 
anesthetized with isoflurane (2-3% in 100% oxygen). The kidneys were harvested, the poles 
excised, and the middle portion contained the pelvis and cortex was homogenized in TRIzol. RNA 
was converted to cDNA using a reverse transcription kit (ThermoFisher K1691). Primers were 
designed using Primar-BLAST (NIH) and purchased from ThermoFisher (see Table 1 for 
sequences). cDNA, diluted primers, and SYBR Green Master Mix (Bio-Rad 1725121) were 
combined in a 96 well plate and analyzed in a CFX Connect Real-Time PCR Detection System. 
Annealing temperature was set to 60°C for all primers and melt curves were generated to assess 
primer specificity. Gene expression was normalized to B-ACTIN and then quantified using the 
comparative CT method (ΔΔCT). 
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Table 1 Primers for qPCR of Kidney Samples 
GENE FWD SEQ REV SEQ 
IL1B TGCCACCTTTTGACAGTGATG ATGTGCTGCTGCGAGATTTG 
IL2 CAAGCAGGCCACAGAATTGAAA GGCACTCAAATGTGTTGTCAGA 
IL4 ACTTGAGAGAGATCATCGGCA AGCTCCATGAGAACACTAGAGTT 
IL5 AGGCTTCCTGTCCCTACTCAT CGCCACACTTCTCTTTTTGGC 
IL6 CTTGGGACTGATGCTGGTG TCCACGATTTCCCAGAGAAC 
IL10 ACTTTAAGGGTTACTTGGGTTGC TTCAGCTTCTCACCCAGGGA 
IL17F CGTGAAACAGCCATGGTCAAG GGGACAGAAATGCCCTGGTT 
IL23 ACCAGCGGGACATATGAATCT AGACCTTGGCGGATCCTTTG 
TNFa TCGTAGCAAACCACCAAGTG CCTTGAAGAGAACCTGGGAG 
MCP1 CCCACTCACCTGCTGCTAC TTCTTGGGGTCAGCACAGA 
COLLAGEN 1 ATCTCCTGGTGCTGATGGAC ACCTTGTTTGCCAGGTTCAC 
FIBRONECTIN CGAGGTGACAGAGACCACAA CTGGAGTCAAGCCAGACACA 
TGFb GTGGAAATCAACGGGATCAG GTTGGTATCCAGGGCTCTCC 
IFNg AGACAATCAGGCCATCAGCAA TGTGGGTTGTTGACCTCAAACT 
B-ACTIN CAGCTGAGAGGGAAATCGTG CGTTGCCAATAGTGATGACC 
2.4 Experiment 4 
Experiment 4 determined whether renal afferent nerve activity differed between kidneys 
of 2K1C or sham mice. 2K1C and sham mice without telemetry units were produced as described 
above. At 3 weeks later, mice were anesthetized with isoflurane and instrumented with femoral 
catheters as described above. Through a retroperitoneal incision, the left and right renal nerves 
were isolated, placed on a bipolar stainless-steel electrodes, cut proximal, and insulated with 
KWIK-SIL. Signals were filtered (300-1000 Hz), digitized (2 kHz), full-wave rectified, and 
integrated (1s time constant) using a Micro1401 and Spike2 software (Cambridge Electronic 
Design). The raw signal was also analyzed by a window discriminator (FHC) to quantify discharge 
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rate. The window was set immediately above the estimated noise level and confirmed to produce 
no events post-mortem. After mice stabilized at 1.8% isoflurane for 20 min, variables were 
recorded for 20 min. Then, animals were euthanized, noise confirmed for both rectified/integrated 
signals and the window discriminator using a 5 min average, and the kidneys harvested and 
weighed. 
2.5 Experiment 5 
Experiment 5 determined whether total renal nerve denervation or selective afferent renal 
denervation lowered ABP in 2K1C mice. Mice were implanted with telemetry units as described 
above. After a 2-week recovery, the left renal artery was isolated and clipped as described above. 
Immediately prior to clipping, total renal nerve denervation was performed unilaterally to the same 
kidney by stripping the artery and vein of nerves and connective tissue and painting the vessels 
with 10% phenol (in 90% ethanol). Selective afferent nerve denervation was performed 
unilaterally to the same kidney by carefully removing connective tissue overlying the renal artery 
and vein and painting the vessels with capsaicin (33mM in 5% ethanol/95% saline) for 10 min 
using a small piece of cotton swab soaked in the capsaicin solution. ABP and heart rate were 
recorded 3 days before and 21 days after 2K1C surgery. Ganglionic blockade with hexamethonium 
(30mg/kg, ip) was performed on days 0, 14, 21 relative to 2K1C surgery. On day 22-23, mice were 
anesthetized with isoflurane and perfused transcardially with 4% paraformaldehyde. Kidneys were 
harvested, weighed, and sectioned at 10µm using a cryostat. Alternate sections were incubated 
with polyclonal antibodies for tyrosine hydroxylase (1:2000, EMD Millipore AB152) or TRPV1 
(1:500, Alomone Labs ACC-030) overnight at 4˚C with 1% donkey serum (ThermoScientific) and 
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visualized after with donkey anti-rabbit Alexa Fluor 647 (1:250, Invitrogen, 4˚C overnight 
incubation). Sections were qualitatively assessed for the presence/absence of immunofluorescent 
signals by an individual blind to the experimental group. A subset of kidneys from Experiment 1 
were included as a positive control. 
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3.0 Statistical Analysis 
All data are presented as mean±SEM plus individual data points when possible. Telemetry, 
ganglionic blockade, and renal mass were analyzed by a 2-way ANOVA (group and kidney). When 
significant F values were obtained, independent or paired t-tests with a layered Bonferroni 
correction was performed to assess group or time differences. The depressor response to ganglionic 
blockade was calculated by the peak drop (1s) versus baseline (300s) value of mean ABP. qPCR 
analysis of renal cytokine expression was compared using a 2-way ANOVA (group and kidney) 
with post hoc testing described above. Responses to stimulation of renal afferents were analyzed 
by comparing baseline (30s) versus peak (1s) segments. SNA responses during spike-triggered 
average were compared using a baseline (100ms) versus peak (10ms) segment. Data was analyzed 
by a 2-way ANOVA (frequency x drug-chlorisondamine-Manning Compound). Renal afferent 
discharge, rectified and integrated (1s time constant) voltage (signal – noise by nerve crush) and 
ABP was averaged over a 20 min period and analyzed using a 2-way ANOVA (group and kidney). 
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4.0 Results 
4.1 Experiment 1: Renal Afferent Stimulation in Mice Produces a Sympathetically-
Mediated Increase in ABP 
Baseline mean ABP and heart rate of mice anesthetized with isoflurane and prepared for 
recordings were 88±4 mmHg and 603±20 bpm, respectively. Electrical stimulation of the right 
renal afferent nerve produced frequency-dependent increases in ABP (Figures 1A, B). Heart rate 
decreased (2Hz: -1±1, 5Hz: -3±1, 10Hz: -18±4*, 20Hz: -19±5*, 30Hz: -17±4*, 50Hz: -24±5* bpm; 
n=6, *P<0.05 vs baseline). Administration of chlorisondamine decreased baseline ABP from 86±3 
to 41±4 mmHg (P<0.01) and largely eliminated these responses (Figures 1A, B). On the other 
hand, blockade of vasopressin receptors did not significantly alter the pressor response (2Hz: 1±1, 
5Hz: 3±1, 10Hz: 5±1, 20Hz: 9±1, 30Hz: 10±2, 50Hz: 10±2 mmHg; n=3, P>0.7 from overall 
ANOVA). 
In a subset of mice (n=4), we performed simultaneous recordings of splanchnic, renal, and 
lumbar SNA and applied single pulses to the contralateral renal nerve to determine whether 
activation of renal afferent nerves increases SNA. Figure 1C illustrates the simultaneous SNA 
recordings and a representative example of the stimulus-triggered averaging of SNA. Stimulation 
of renal afferents significantly increased contralateral renal, splanchnic, and lumbar SNA with a 
latency to peak ~100-200 ms (Figure 1D).  
A final set of experiments repeated these stimulations in mice anesthetized with urethane. 
Renal afferent stimulation produced frequency-dependent pressor responses (2Hz: -1±1, 5Hz: 3±1, 
10Hz: 7±1, 20Hz: 11±2, 30Hz: 12±3, 50Hz: 12±3 mmHg; n=3) which were also blocked by 
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chlorisondamine (2Hz: 0±0, 5Hz: 0±0, 10Hz: 1±1, 20Hz: 0±1, 30Hz: 1±1, 50Hz: 2±1 mmHg; 
n=3). Baseline mean ABP and heart rate in urethane-anesthetized mice was 79±4mmHg and 
658±16 bpm, respectively. 
 
Figure 1  (A) Raw traces of ABP and mean ABP (white) during electrical stimulation of the right renal sensory nerve 
(1 ms pulse, 200 uA) at 5, 10, and 20 Hz before and after the ganglionic blocker chlorisondamine. (B) Mean±SEM 
and individual data points of the peak change in mean ABP (*P<0.01 vs chlorsidonamine; #P<0.05 vs smaller 
frequency). (C) (LEFT) Simultaneous recording of ABP and renal, splanchnic, lumbar, and contralateral renal SNA 
in a control mouse. Note pulse-synchronous activity in all 4 sympathetic nerves. (RIGHT) Example of stimulus-
triggered averaging during electrical stimulation of the contralateral renal afferent nerve (1 ms, 1 Hz, 100 uA, 30 
sweeps) revealed an increase in renal, splanchnic, and lumbar SNA between 100-200 ms. (D) Mean±SEM and 
individual data points of latency to peak (ms) and peak SNA during stimulus-triggered averaging. Baseline nerve 
activity was normalized to 100%. 
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4.2 Experiment 2: Location of Renal Sensory Neurons in the Dorsal Root Ganglia 
To anatomically map the location of renal sensory neurons in the DRG, mice received an 
injection of WGA-Alexa Fluor 488 or 594 into the right and left kidney, respectively. Figure 2A 
illustrates a representative single injection located on the pelvic wall with no tracer deposited in 
the cortex. Each injection site produced WGA-positive nerve fibers projecting along the pelvic 
wall. Figure 2A also illustrates examples of labeled cells in the right and left DRG. Figure 2B 
illustrates the greatest number of labeled cells was located at T11-L1 and T12-L2 for the right and 
left kidney, respectively. No cells were observed at T5 or T6 levels (data not shown), and few cells 
were labeled in the contralateral DRG (0.7±0.2 cells per DRG at T11-L2). In addition, the nodose 
ganglia did not contain labeled cells in 3 of 4 mice (Figure 2B). The only mouse that produced 
labeling in the nodose ganglia resulted in a few cells on the right side only. Finally, total renal 
nerve denervation with 10% phenol eliminated the number of labeled cells in the DRG at any level 
(0±0 cells per DRG at T11-L2, n=3). 
 
Figure 2  (A) Digital images of a single kidney injection site and labeled DRG neurons. (B) Mean±SEM and individual 
data points for the number of labelled-DRG-neurons per spinal level after injection of WGA-Alexa Fluor 488 or 594 
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into the right and left kidney, respectively. Total renal nerve denervation eliminated the number of labeled cells in the 
DRG at any level (0±0 cells per DRG at T11-L2, n=3). 
4.3 Experiment 3: 2K1C Hypertension Model in Mice 
An initial set of experiments established the 2K1C mouse model of neurogenic 
hypertension. Unilateral placement of a PTFE clip to model renal stenosis significantly increased 
mean ABP without changes in heart rate (Figure 3A). These differences were present at day and 
nighttime periods (data not shown). Ganglionic blockade with hexamethonium produced 
significantly greater falls in mean ABP at day 14 and 21 versus Day 0 (Figure 3B). Renal mass of 
2K1C mice was significantly less in clipped versus unclipped kidneys (Figure 3C). Qualitative 
analysis of renal histology indicated the presence of damaged glomeruli and renal casts in 2K1C-
clipped versus 2K1C-unclipped or sham mice. qPCR analysis of renal samples revealed significant 
increases in mRNA for various cytokines in 2K1C-clipped versus 2K1C-unclipped or sham 
kidneys (Table 2). 
 
Figure 3 (A) Mean±SEM of 24-h mean ABP and heart rate before and after unilateral clipping of the left renal artery. 
*P<0.05 versus avg baseline (1-way ANOVA and paired t-tests with layered Bonferonni correction). (B) Mean±SEM 
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and individual data points of changes in mean ABP in response to ganglionic blocker hexamethonium (30mg/kg, ip). 
*P<0.05 vs Day 0 (paired t-test). (C) Images of 2K1C unclipped versus clipped kidneys to illustrate reduction in renal 
mass after unilateral clipping. Mean±SEM and individual data points of unclipped and clipped kidneys in 2K1C mice. 
*P<0.05 vs unclipped. (D) Renal histology revealed the presence of damaged glomeruli (filled arrow) and renal casts 
(filled arrow) in clipped but not unclipped kidneys of 2K1C mice. 
 
Table 2 qPCR Analysis of Kidneys from 2K1C and Sham Mice. Values were normalized by B-actin and expressed 
mean±SEM 2ΔΔCT. Values were statistically analyzed by a 2-way ANOVA (group vs kidney). *P<0.05 unclipped 
vs clipped kidney in same animal. #P<0.05 right unclipped SHAM kidney vs 2K1C-clipped
 SHAM (n=4)  2K1C (n=4)  
Cytokine Unclipped-Left   Unclipped-Right Clipped-Left  Clipped-Right 
IL1b 1.0±0.3 1.1±0.3 1.4±0.3 7.3±2.3 *# 
IL2 1.0±0.2 1.1±0.3 1.1±0.5 3.7±0.7 *# 
IL5 1.0±0.3 0.8±0.3 1.1±0.3 0.9±0.1 
IL6 1.0±0.3 0.4±0.1 0.6±0.1 2.9±0.7 *# 
IL10 1.0±0.3 0.4±0.1 0.8±0.1 3.3±0.8 *# 
IL17F 1.0±0.1 1.0±0.1 1.3±0.3 0.8±0.3 
IL23 1.0±0.1 1.0±0.1 2.3±0.6 1.2±0.1 
TNFa 1.0±0.1 0.8±0.1 0.8±0.1 3.4±1.0 *# 
MCP1 1.0±0.1 1.0±0.1 1.1±0.1 7.9±2.0 *# 
Collagen 1 1.0±0.1 1.1±0.2 1.0±0.1 5.3±1.3 *# 
Fibronectin 1.0±0.1 1.0±0.1 1.1±0.1 5.4±1.3 *# 
TGFb 1.0±0.1 1.0±0.1 1.2±0.1 2.3±0.3 *# 
IFNg 1.0±0.1 1.0±0.1 1.4±0.2 3.6±0.6 *# 
 
4.4 Experiment 4: Renal Afferent Nerve Activity is Elevated in 2K1C Mice 
Renal afferent nerve recordings were performed to assess differences in baseline renal 
sensory nerve activity between 2K1C and sham mice. Baseline mean ABP was significantly 
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elevated in this group of anesthetized 2K1C versus sham mice (97±3 vs 86±2 mmHg, respectively; 
P<0.05 t-test). A qualitative assessment of the renal afferent recording suggested the presence of 
single-units as indicated by the shape and duration of the voltage events. Quantitative analysis 
revealed that both renal afferent discharge and rectified/integrated voltage was significantly 
elevated in clipped kidneys of 2K1C mice versus unclipped kidneys of 2K1C or sham mice (Figure 
4B). In this cohort, renal mass was significantly lower in 2K1C-clipped versus 2K1C-unclipped 
or sham kidneys (2K1C-clipped: 68±10 vs 2K1C-unclipped: 181±12 or sham: 182±8 or sham: 
171±7 mg, P<0.05 t-tests). A linear regression revealed a significant inverse relationship between 
renal afferent discharge (r=0.696, P<0.001) or voltage (r=0.688, P<0.001) versus renal mass (plots 
not shown). 
 
Figure 4  (A) Raw traces of ABP, mean ABP (white), and renal afferent nerve activity of a sham, 2K1C-unclipped, 
and 2K1C-clipped kidneys. (B) Mean±SEM and individual data points of renal afferent discharge and full-wave 
rectified/integrated renal afferent voltage. *P<0.05 2K1C-clipped vs 2K1C-unclipped, #P<0.05 2K1C-clipped vs 
sham, unpaired 2-tailed t-test 
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4.5 Experiment 5: Total or Selective Renal Sensory Nerve Denervation Lowers ABP in 
2K1C Mice 
To determine the contribution of renal efferent versus renal afferent nerves to 2K1C 
hypertension, ABP telemetry recordings were performed in 2K1C mice with ipsilateral renal 
denervation or selective ipsilateral renal afferent denervation. Implantation of a renal clip 
significantly increased mean ABP from baseline levels in sham, ipsilateral renal denervation, and 
selective renal afferent denervation groups throughout the experimental protocol (P<0.05 from 
overall ANOVAs). However, mean ABP was significantly lower in 2K1C-ipsilateral renal 
denervation versus 2K1C mice at Days 7-21 (Figure 5). In addition, mean ABP was also 
significantly lower of 2K1C-capsaicin versus 2K1C mice at Days 1-3 and 11-21 (Figure 5). No 
significant differences were observed in mean ABP between 2K1C-ipsilateral denervation versus 
2K1C-capsaicin. Ganglionic blockade with hexamethonium did not produce a statistically greater 
depressor response between Day 0, 14, or 21 in 2K1C-ipsilateral renal denervation (P=0.0967 from 
overall 1-way ANOVA) or 2K1C-capsaicin (P=0.06488 from overall 1-way ANOVA) groups 
(Figure 5B). Renal mass was significantly lower in clipped versus unclipped kidneys of 2K1C 
(105±14 vs 191±5g, respectively; P<0.01), 2K1C-ipsilateral denervation (136±16 vs 188±6g, 
respectively, P<0.01), and 2K1C-capsaicin (125±11 vs 184±9g, respectively; P<0.01).  
Immunofluorescence analysis confirmed the presence of TRPV1- and tyrosine 
hydroxylase-positive fibers in the kidney of 2K1C mice (Figure 6). However, a qualitative analysis 
revealed that both markers were absent in mice with ipsilateral renal denervation. Tyrosine 
hydroxylase, but not TRPV1, fibers were present in mice with selective renal afferent denervation. 
It is noteworthy that 3 mice in the renal afferent denervation group did display TRPV1 
immunofluorescence in the pelvic wall. Consequently, these mice were excluded from the BP data 
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presented in Figure 5 but had mean ABP values on Day 14 and 21 of 123±5 and 125±4 mmHg, 
respectively. 
 
 
Figure 5  (A) Mean±SEM of 24-h mean ABP before and after unilateral clipping of the left renal artery of mice 
receiving ipsilateral renal denervation or selective afferent renal denervation. Control mice have been replotted from 
Figure 1. *P<0.05, sham vs ipsilateral renal denervation, #P<0.05, control vs capsaicin (2-way ANOVA followed by 
t-test with layered Bonferonni correction). (B) Mean±SEM and individual data points of changes in mean ABP in 
response to ganglionic blocker hexamethonium (30mg/kg, ip). *P<0.05 vs Day 0 (paired t-test). Ganglionic blockade 
with hexamethonium did not produce a greater depressor response between Day 0, 14, or 21 of ipsilateral renal 
denervation (P=0.0967 from overall 1-way ANOVA) or capsaicin-treated (P=0.06488 from overall 1-way ANOVA) 
groups. Confirmation of the denervation using immunofluorescence for TRPV1 and tyrosine hydroxylase is presented 
in Figure 6. 
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Figure 6  Digital images of immunofluorescence labeling for TRPV1 and tyrosine hydroxylase in clipped kidneys of 
control, ipsilateral denervated, and capsaicin (renal afferent denervated) mice. Note the presence of TRPV1- versus 
tyrosine hydroxylase-positive fibers in the kidney of 2K1C sham mice that were predominantly localized to the pelvis 
versus cortex and medulla, respectively. However, both markers were absent in mice with ipsilateral renal denervation. 
Tyrosine hydroxylase, but not TRPV1, fibers were present in mice with selective renal afferent denervation. White 
arrows indicate positive-labeled terminals. Scale bar = 100 µm. 
 22 
5.0 Discussion 
Recent clinical trials and basic research studies underscore the importance of renal afferent 
nerves in cardiovascular regulation and hypertension (DiBona and Kopp 1997, Krum, Schlaich et 
al. 2009, Krum, Schlaich et al. 2014, Azizi, Sapoval et al. 2015, Osborn and Foss 2017, Townsend, 
Mahfoud et al. 2017). Although mice represent the most common biomedical research model 
currently employed, no information is currently available of mouse renal sensory nerves with 
respect to the function, anatomical location, and contribution to hypertension. The purpose of this 
study was to lay the foundational framework and test the contribution of mouse renal sensory 
nerves to a renal nerve-dependent model of hypertension. For the first time, we have documented 
that stimulation of these afferent nerves produced a frequency-dependent and sympathetically-
mediated increase in ABP. Simultaneous recordings of multiple sympathetic nerves revealed, for 
the first time, that activation of mouse renal sensory nerves increased splanchnic, lumbar, and renal 
SNA. Furthermore, the anatomical location of mouse renal sensory cell bodies are distributed in 
T11-L2 DRG. Next, paired renal afferent nerve recordings provide the first evidence that mouse 
renal sensory nerve activity is elevated in the 2K1C model of hypertension. Finally, both ipsilateral 
renal denervation and selective afferent denervation lowered ABP in 2K1C mice. Altogether, these 
findings provide multiple novel observations in the mouse to suggest that renal afferent nerves 
become hyperactive to elevate SNA and ABP in 2K1C hypertension. 
The majority, if not all, of previous studies to understand the function of renal sensory 
nerves have been performed in larger animal models (i.e., cats, dogs, and rats). These studies have 
largely employed supraphysiological stimulation parameters (>30 Hz) and reduced preparations 
(i.e., barodenervated and vagotomized) to report that renal afferent nerve stimulation increases 
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ABP and may stimulate vasopressin secretion (Caverson and Ciriello 1987, Caverson and Ciriello 
1988, Simon, Kasting et al. 1989). To date, no such data existed in the mouse. The current findings 
indicate renal afferent stimulation produced frequency-dependent and sympathetically-mediated 
increases in ABP. First, stimulation frequencies of 5 or 10 Hz increased mean ABP. Although 
these frequencies are equivalent to the discharge rate of renal afferent nerves in the 2K1C mouse 
reported herein, single-units were not identified, and the electrical stimulation paradigms may not 
reflect the patterning of renal afferent discharge. Second, blockade of ganglionic 
neurotransmission, but not vasopressin receptors, eliminated this pressor response. Next, to 
determine the extent by which renal afferent activation altered SNA, simultaneous recording of 
multiple sympathetic nerves revealed an increase in splanchnic, contralateral renal, and lumbar 
SNA. The latency (~100-200ms) suggests the involvement of supraspinal pathways and likely 
involves various neuronal populations within the hypothalamus and hindbrain (Caverson and 
Ciriello 1988, Ammons 1992, Xu, Zheng et al. 2015). The relative contribution of sympathetic 
efferent nerves innervating the muscle, contralateral kidney, or mesentery to the chronic 2K1C 
hypertension remains unclear. However, renal denervation of the contralateral or unclipped kidney 
in 2K1C rats did not affect ABP (Katholi, Whitlow et al. 1982). Altogether, these data provide 
multiple novel observations in the mouse that renal afferent neurons can elevate ABP through 
splanchnic, renal, and lumbar SNA. 
Renal afferent fibers contain different fiber types including chemo- versus 
mechanosensitive or myelinated versus unmyelinated (Recordati, Moss et al. 1978, Recordati, 
Moss et al. 1980, Recordati, Moss et al. 1981, Simon and Schramm 1984, Kopp 2015) that project 
to the lower thoracic and upper lumbar spinal segments (Ciriello and Calaresu 1983, Donovan, 
Wyss et al. 1983, Kuo, Nadelhaft et al. 1983). Such data is solely based on studies performed in 
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rats or larger animal models. The present study documents, for the first time, that injection of 
neuroanatomical tracers into the mouse renal pelvis labeled renal sensory cell bodies primarily at 
the T11-L2 DRG. The renal pelvis was targeted since previous studies suggest sensory fibers 
primarily innervate this region of the kidney (Marfurt and Echtenkamp 1991, Kopp 2015). 
However, we fully acknowledge that our injections may have missed sensory fibers innervating 
the renal medulla or cortex and therefore underestimate the number of renal neurons. These 
findings also highlight that the parasympathetic nervous system does not innervate the mouse 
kidney. Despite the anatomical location of renal sensory neurons, little is known regarding the 
neurochemical phenotype and how the neurochemistry corresponds to the properties or response 
profiles of renal sensory fibers. For example, high concentrations of the TRPV1 agonist capsaicin 
is used to ablate renal sensory afferents and assumes the majority, if not all, renal sensory neurons 
express TRPV1. However, the relative expression of TRPV1 (or other common sensory 
phenotypes) in renal sensory neurons has not been defined for any species. Freisinger (Freisinger, 
Schatz et al. 2013) reported renal sensory neurons may be distinguished by a tonic versus phasic 
firing activity and the presence versus absence of Nav1.8 or 1.9 expression. How different 
neurochemically distinct populations subserve different response profiles or sensory functions to 
impact cardiovascular function remains unexplored. 
A major finding of the present study was renal afferent nerve activity of 2K1C-clipped 
kidneys was elevated, and denervation of these renal sensory fibers lowered ABP in 2K1C 
hypertensive mice. These observations extend the original reports that total renal denervation or 
dorsal rhizotomy lowered ABP in 2K1C or 1-kidney-1-clip rats (Katholi, Whitlow et al. 1982, 
Katholi, Winternitz et al. 1982, Wyss, Aboukarsh et al. 1986). However, our findings do disagree 
with a prior study that reported no differences in baseline renal afferent nerve activity between 
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sham versus 2K1C rats (Kopp and Buckley-Bleiler 1989). Acute insertion of the clip will cause 
renal ischemia or a reduction in renal perfusion pressure to activate renal sensory nerves, but the 
mechanism(s) that chronically drive renal afferent activity remain unclear. Removal of the clip at 
6 weeks after insertion normalized ABP of 2K1C rats within days, thereby suggesting the renal 
stenosis provides a chronic stimulus (Katholi, Whitlow et al. 1982). Renal afferent nerves are 
mechanosensitive (Niijima 1975, Recordati, Moss et al. 1978, Kopp 2015), and structural changes 
reflected by the reduced renal mass and renal damage may alter the mechanosensitivity and 
contribute to the disease. Kopp et al (Kopp and Buckley-Bleiler 1989) reported 2K1C hypertensive 
rats displayed attenuated reno-renal reflexes in both kidneys rather than the stenosed kidney only. 
Renal afferents are also chemosensitive (Recordati, Moss et al. 1978, Recordati, Moss et al. 1980, 
Recordati, Moss et al. 1981, Kopp 2015), and the elevated activity in 2K1C-clipped kidneys may 
reflect changes in the local chemical environment. In this regard, qPCR indicated increased 
expression of numerous cytokines in the clipped but not unclipped kidneys of 2K1C mice. A subset 
of these cytokines is also increased in the kidneys of deoxycorticosterone-salt hypertension 
(Banek, Knuepfer et al. 2016). Cytokines can activate sensory nerves originating in other end-
organs (Cook, Christensen et al. 2018, Dong and Dong 2018). Whether renal sensory nerves 
respond to local cytokines or how the renal sensory innervation of the kidney changes in such 
disease states remains unknown.  
Unilateral renal denervation or selective sensory denervation of the clipped kidney lowered 
ABP in 2K1C mice. We qualitatively assessed the degree of denervation by the presence or 
absence of tyrosine hydroxylase or TRPV1 immunoreactivity. Although prior studies have directly 
assayed renal norepinephrine or CGRP content (Foss, Wainford et al. 2015, Banek, Knuepfer et 
al. 2016, Foss, Fink et al. 2016, Foss, Fiege et al. 2018), there is not a clearly defined standard or 
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tissue level for CGRP levels (as for norepinephrine) regarding quantification of a denervated 
versus partially-denervated kidney. Herein, we were able to discriminate between these two groups 
by the presence or absence of TRPV1-positive fibers. Indeed, a small cohort of mice (n=3) had 
residual TRPV1 immunofluorescence and displayed mean ABP values similar to 2K1C animals. 
Unilateral denervation was performed in the present study at the time of renal artery clipping rather 
than after hypertension was established. However, prior studies in rats reported that complete 
unilateral denervation of the clipped kidney but not the contralateral kidney at 6 weeks post-
clipping lowered ABP in this model (Katholi, Whitlow et al. 1982, Katholi, Winternitz et al. 1982). 
Clearly, future studies will need to evaluate the impact of selective afferent denervation after 
hypertension has been established. Although renal denervation lowered ABP of 2K1C mice in the 
present study, ABP remained elevated above baseline values (see Figure 5) thereby suggesting 
additional factors contribute to the hypertension in this model. Such factors likely include renin-
angiotensin-aldosterone system activation, renal dysfunction, and vascular dysfunction.  
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